 The study aimed to quantify worldwide cumulative coverage of publicly funded HPV immunization programs up to 2014, and the potential impact on future cervical cancer cases and deaths. The authors found that from June 2006 to October 2014, 64 countries nationally, for countries sub-nationally, and 12 overseas territories had implemented HPV immunization programs. An estimated 118 million women had been targeted through these programs, but only 1% were from low-income or lower middle-income countries. The authors also found that in more developed regions, 33.6% of females aged 10 to 20 years received the full course of vaccine, compared with only 2.7% of females in less developed regions. The impact of the vaccine will be higher in upper middle-income countries, 178 backslash U2008192 averted cases by age 75 years, than in high-income countries, 165 backslash U2008033 averted cases, despite the lower number of vaccinated women. The authors suggest that rapid rollout of the vaccine in low-income and middle-income countries might be the only feasible way to narrow present inequalities in cervical cancer burden and prevention. This article was authored by Dr. Lya Bruni, M.D., MIA Ideas, Ph.D., Leslie Bionueva-Roses, M.D., and others. We are article.tv, links in the description below.